ipilimumab,nivolumab,cabozantinib
exelixis,bms
['nivo', 'kcsm,(-skcsm)', 'cabozantinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'cosmic-313', 'ipilimumab', 'nivolumab', 'renal,(-adrenal)']
cosmic-313: cabozantinib, nivolumab, and ipilimumab in previously untreated patients with advanced renal cell carcinoma #kcsm #kidneycancer #rcc #esmo22 #immunotherapy
News and views from the world of clinical oncology and hematology